메뉴 건너뛰기




Volumn 108, Issue 5, 2012, Pages 913-922

Efficacy and safety of prophylaxis with once-weekly BAY 79-4980 compared with thrice-weekly rFVIII-FS in haemophilia A patients: A randomised, active-controlled, double-blind study

Author keywords

Haemophilia; PEGylated liposome; Prophylaxis; rFVIII FS

Indexed keywords

BAY 79 4980; LIPID; LIPOSOME; RECOMBINANT BLOOD CLOTTING FACTOR 8; SUCROSE FORMULATED RECOMBINANT FACTOR 8; UNCLASSIFIED DRUG;

EID: 84870336472     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-03-0188     Document Type: Article
Times cited : (26)

References (14)
  • 3
    • 0034913232 scopus 로고    scopus 로고
    • Barriers to compliance with prophylaxis therapy in haemophilia
    • Hacker MR, Geraghty S, Manco-Johnson M. Barriers to compliance with prophylaxis therapy in haemophilia. Haemophilia 2001; 7: 392-396.
    • (2001) Haemophilia , vol.7 , pp. 392-396
    • Hacker, M.R.1    Geraghty, S.2    Manco-Johnson, M.3
  • 4
    • 34547631468 scopus 로고    scopus 로고
    • The risk associated with indwelling catheters in children with haemophilia
    • Ljung R. The risk associated with indwelling catheters in children with haemophilia. Br J Haematol 2007; 138: 580-586.
    • (2007) Br J Haematol , vol.138 , pp. 580-586
    • Ljung, R.1
  • 5
    • 73949135703 scopus 로고    scopus 로고
    • Longer-acting factor VIII to overcome limitations in haemophilia management: The PEGylated liposomes formulation issue
    • Di Minno G, Cerbone AM, Coppola A, et al. Longer-acting factor VIII to overcome limitations in haemophilia management: the PEGylated liposomes formulation issue. Haemophilia 2010; 16 (Suppl 1): 2-6.
    • (2010) Haemophilia , vol.16 , Issue.SUPPL. 1 , pp. 2-6
    • Di Minno, G.1    Cerbone, A.M.2    Coppola, A.3
  • 6
    • 20444503381 scopus 로고    scopus 로고
    • Factor VIII efficient and specific noncovalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy
    • Baru M, Carmel-Goren L, Barenholz Y, et al. Factor VIII efficient and specific noncovalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacy. Thromb Haemost 2005; 93: 1061-1068.
    • (2005) Thromb Haemost , vol.93 , pp. 1061-1068
    • Baru, M.1    Carmel-Goren, L.2    Barenholz, Y.3
  • 7
    • 38349083504 scopus 로고    scopus 로고
    • Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A
    • Powell JS, Nugent DJ, Harrison JA, et al. Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A. J Thromb Haemost 2008; 6: 277-283.
    • (2008) J Thromb Haemost , vol.6 , pp. 277-283
    • Powell, J.S.1    Nugent, D.J.2    Harrison, J.A.3
  • 8
    • 33845241302 scopus 로고    scopus 로고
    • Prolonged bleeding-free period following prophylactic infusion of recombinant factor VIII reconstituted with pegylated liposomes
    • Spira J, Plyushch OP, Andreeva TA, Andreev Y. Prolonged bleeding-free period following prophylactic infusion of recombinant factor VIII reconstituted with pegylated liposomes. Blood 2006; 108: 3668-3673.
    • (2006) Blood , vol.108 , pp. 3668-3673
    • Spira, J.1    Plyushch, O.P.2    Andreeva, T.A.3    Andreev, Y.4
  • 9
    • 51349110498 scopus 로고    scopus 로고
    • Evaluation of liposomal dose in recombinant factor VIII reconstituted with pegylated liposomes for the treatment of patients with severe haemophilia A
    • Spira J, Plyushch OP, Andreeva TA, Khametova RN. Evaluation of liposomal dose in recombinant factor VIII reconstituted with pegylated liposomes for the treatment of patients with severe haemophilia A. Thromb Haemost 2008; 100: 429-434.
    • (2008) Thromb Haemost , vol.100 , pp. 429-434
    • Spira, J.1    Plyushch, O.P.2    Andreeva, T.A.3    Khametova, R.N.4
  • 10
    • 51249103798 scopus 로고    scopus 로고
    • Infusion rates of recombinant FVIII-FS with PEGylated liposomes in haemophilia A
    • Martinowitz U, Lalezari S, Luboshitz J, Lubetsky A, Spira J. Infusion rates of recombinant FVIII-FS with PEGylated liposomes in haemophilia A. Haemophilia 2008; 14: 1122-1124.
    • (2008) Haemophilia , vol.14 , pp. 1122-1124
    • Martinowitz, U.1    Lalezari, S.2    Luboshitz, J.3    Lubetsky, A.4    Spira, J.5
  • 11
    • 38349109840 scopus 로고    scopus 로고
    • Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: Experience in the standard clinical setting
    • Musso R, Santagostino E, Faradji A, et al. Safety and efficacy of sucrose-formulated full-length recombinant factor VIII: experience in the standard clinical setting. Thromb Haemost 2008; 99: 52-58.
    • (2008) Thromb Haemost , vol.99 , pp. 52-58
    • Musso, R.1    Santagostino, E.2    Faradji, A.3
  • 12
    • 70449601973 scopus 로고    scopus 로고
    • Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment
    • Den Uijl I, Mauser-Bunschoten EP, Roosendaal G, Schutgens R, Fischer K. Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment. Haemophilia 2009; 15: 1215-1218.
    • (2009) Haemophilia , vol.15 , pp. 1215-1218
    • Den Uijl, I.1    Mauser-Bunschoten, E.P.2    Roosendaal, G.3    Schutgens, R.4    Fischer, K.5
  • 13
    • 47649131839 scopus 로고    scopus 로고
    • Plasma and albumin-free recombinant factor VIII: Pharmacokinetics, efficacy and safety in previously treated pediatric patients
    • Blanchette VS, Shapiro AD, Liesner RJ, et al. Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients. J Thromb Haemost 2008; 6: 1319-1326.
    • (2008) J Thromb Haemost , vol.6 , pp. 1319-1326
    • Blanchette, V.S.1    Shapiro, A.D.2    Liesner, R.J.3
  • 14
    • 84871386504 scopus 로고    scopus 로고
    • World Federation of Hemophilia Physical Examination Score (also called the Gilbert Score)
    • Orthopedic Advisory Committee of WFH. Available at: Accessed May 11, 2012
    • Gilbert M, Orthopedic Advisory Committee of WFH. World Federation of Hemophilia Physical Examination Score (also called the Gilbert Score). World Federation of Hemophilia. Available at: http://www.wfh.org/2/7/7_0_Assess ment_Tools_Gilbert_Score.htm. Accessed May 11, 2012.
    • World Federation of Hemophilia
    • Gilbert, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.